From: The many faces of diabetes. Is there a need for re-classification? A narrative review
Time | Development |
---|---|
 | Variations of diets |
550 Common Era (CE) | Bleeding, emetics and narcotics |
1921 | Discovery of insulin |
1923 | Commercial animal insulin available |
1936 | Introduction of long-acting insulin |
1941 | Urine-testing tablets for sugar available |
1949 | Syringe drivers for insulin |
1961 | Glucagon available for hypoglycemia |
1971 | The first blood glucose meter developed |
1972 | Metformin approved for use in Canada |
1983 | Recombinant insulin developed |
1995 | First Alpha-glucosidase inhibitor (AGI) Acarbose |
1996 | First Thiazolidinedionederivate (TZD) Troglitazone |
1997 | First Meglitinide Repaglinide |
2005 | First Amylin agonist pramlintide First Glucagon-Like Peptide 1(GLP-1) receptor agonist (exenatide) |
2006 | First Dipeptidyl peptidase-4 (DPP-4) inhibitor (sitagliptin) |
2008 | Colesevelam approved for diabetes |
2009 | Bromocriptine approved for diabetes |
2013 | First Sodium Glucose Transporter-2 (SGLT-2) inhibitor (canagliflozin) |